Skip to main content
. Author manuscript; available in PMC: 2017 Nov 15.
Published in final edited form as: Pediatr Infect Dis J. 2014 Jun;33(6):e158–e161. doi: 10.1097/INF.0000000000000238

Figure 1.

Figure 1

Trends in ciprofloxacin-resistant (blue squares) and levofloxacin-resistant (red dots) Gram-negative bacilli infections among hospitalized children per 1000 admissions, and ciprofloxacin and levofloxacin use expressed as doses administered and days of therapy per 1000 patient-days, Alfred I. duPont Hospital for Children 2001–2009. Sloping of ciprofloxacin resistance (blue line) and levofloxacin resistance (red line) overtime are shown